---
figid: PMC4837572__AN20758251-28-058-g003
figlink: /pmc/articles/PMC4837572/figure/F3/
number: Fig. 3
caption: 'Synaptic transmission: lipid-protein interactions. The neurotransmitter
  is released from the synaptic vesicles upon fusion (exocytosis) with the presynaptic
  membrane at a specific site (termed active zone) in response to Ca2+ influx via
  potential-gated Ca-channels. The vesicle fusion is governed by proteins forming
  a SNARE complex (synaptobrevin, syntaxin, SNAP-25) and is dictated by numerous cholesterol-binding
  proteins (synaptotagmin, Munc-18, NCS-1) and signaling molecules (protein kinases,
  NADPH-oxidase/Nox). After fusion, the protein and lipid components of the vesicles
  undergo clathrin-mediated endocytosis. The vast majority of synaptic vesicles form
  the reserve pool, which maintains neurotransmission during prolonged synaptic activity.
  These vesicles are translocated into the active zone through an actin-and synapsin-dependent
  pathway. Glutamate released from the synaptic vesicles changes the Na+/Ca2+ conductivity
  of the postsynaptic membrane by activating AMPA/NMDA receptors. The surface expression
  of the postsynaptic receptors is dependent on the exo-and endocytotic trafficking
  of these receptors, which is regulated by small GTPase (Rab11) and protein kinase
  (Cdc42, GSK3β, phosphoinositol-3-kinase/PI-3-K). The receptor-dependent signaling
  is associated with many proteins (Src, ERC, Cav-1). As illustrated in Fig.2. Cholesterol
  molecules and its clusters are shown in black, phosphoinositol-4,5-biphosphates
  (PI-4,5-P2,) in red, and cholesterol/PI-4,5-P2-binding proteins. See text for a
  detailed explanation.'
pmcid: PMC4837572
papertitle: 'Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative
  Diseases and Synaptic Dysfunction.'
reftext: A. M. Petrov, et al. Acta Naturae. 2016 Jan-Mar;8(1):58-73.
pmc_ranked_result_index: '78802'
pathway_score: 0.6087751
filename: AN20758251-28-058-g003.jpg
figtitle: 'Synaptic transmission: lipid-protein interactions'
year: '2016'
organisms: Homo sapiens
ndex: d851b523-df37-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4837572__AN20758251-28-058-g003.html
  '@type': Dataset
  description: 'Synaptic transmission: lipid-protein interactions. The neurotransmitter
    is released from the synaptic vesicles upon fusion (exocytosis) with the presynaptic
    membrane at a specific site (termed active zone) in response to Ca2+ influx via
    potential-gated Ca-channels. The vesicle fusion is governed by proteins forming
    a SNARE complex (synaptobrevin, syntaxin, SNAP-25) and is dictated by numerous
    cholesterol-binding proteins (synaptotagmin, Munc-18, NCS-1) and signaling molecules
    (protein kinases, NADPH-oxidase/Nox). After fusion, the protein and lipid components
    of the vesicles undergo clathrin-mediated endocytosis. The vast majority of synaptic
    vesicles form the reserve pool, which maintains neurotransmission during prolonged
    synaptic activity. These vesicles are translocated into the active zone through
    an actin-and synapsin-dependent pathway. Glutamate released from the synaptic
    vesicles changes the Na+/Ca2+ conductivity of the postsynaptic membrane by activating
    AMPA/NMDA receptors. The surface expression of the postsynaptic receptors is dependent
    on the exo-and endocytotic trafficking of these receptors, which is regulated
    by small GTPase (Rab11) and protein kinase (Cdc42, GSK3β, phosphoinositol-3-kinase/PI-3-K).
    The receptor-dependent signaling is associated with many proteins (Src, ERC, Cav-1).
    As illustrated in Fig.2. Cholesterol molecules and its clusters are shown in black,
    phosphoinositol-4,5-biphosphates (PI-4,5-P2,) in red, and cholesterol/PI-4,5-P2-binding
    proteins. See text for a detailed explanation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCH
  - SRC
  - PRKCZ
  - PRKCG
  - CLTC
  - SERPINA4
  - PRKCI
  - SNAP25
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - CLTB
  - PIK3CD
  - PIK3CG
  - ACTA2
  - PRKACG
  - ACTC1
  - ACTG1
  - ACTG2
  - ACTB
  - PRKAR2B
  - PRKCQ
  - CAV1
  - AKT3
  - CLTA
  - PIK3CA
  - PRKCD
  - PRKCE
  - SLC1A3
  - MAPK1
  - MAPK3
  - GSK3B
  - MARCKS
  - C6orf15
  - AKT2
  - TFAP2A
  - CDC42
  - PRKCA
  - PRKCB
  - PIK3R6
  - NCS1
  - ACTA1
  - PRKACA
  - PRKACB
  - BRD2
  - CAMK2B
  - PIK3R5
  - AKT1
  - PIK3CB
  - PRKD3
  - PIK3R4
  - PIK3R3
  - AMPA
  - Cancer
genes:
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: clathrin
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTC
  entrez: '1213'
- word: PI-4
  symbol: PI4
  source: hgnc_prev_symbol
  hgnc_symbol: SERPINA4
  entrez: '5267'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: SNAP-25
  symbol: SNAP-25
  source: hgnc_alias_symbol
  hgnc_symbol: SNAP25
  entrez: '6616'
- word: PKA,
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA,
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA,
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: clathrin
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTB
  entrez: '1212'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA2
  entrez: '59'
- word: PKA,
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTC1
  entrez: '70'
- word: actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG1
  entrez: '71'
- word: actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG2
  entrez: '72'
- word: actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTB
  entrez: '60'
- word: PKA,
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: Cav-1
  symbol: CAV1
  source: hgnc_symbol
  hgnc_symbol: CAV1
  entrez: '857'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: clathrin
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTA
  entrez: '1211'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: EAAT1
  symbol: EAAT1
  source: hgnc_alias_symbol
  hgnc_symbol: SLC1A3
  entrez: '6507'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: MARCKS
  symbol: MARCKS
  source: hgnc_symbol
  hgnc_symbol: MARCKS
  entrez: '4082'
- word: STG
  symbol: STG
  source: hgnc_alias_symbol
  hgnc_symbol: C6orf15
  entrez: '29113'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AP-2
  symbol: AP-2
  source: hgnc_alias_symbol
  hgnc_symbol: TFAP2A
  entrez: '7020'
- word: Cdc42
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: NCS-1
  symbol: NCS-1
  source: hgnc_alias_symbol
  hgnc_symbol: NCS1
  entrez: '23413'
- word: actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA1
  entrez: '58'
- word: PKA,
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA,
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: Nat
  symbol: NAT
  source: hgnc_alias_symbol
  hgnc_symbol: BRD2
  entrez: '6046'
- word: CAMK-II
  symbol: CAMK2
  source: hgnc_alias_symbol
  hgnc_symbol: CAMK2B
  entrez: '816'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
chemicals:
- word: AMPA
  source: MESH
  identifier: D018350
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
